skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Potent 1,2,4-Triazino[5,6 b ]indole-3-thioether Inhibitors of the Kanamycin Resistance Enzyme Eis from Mycobacterium tuberculosis

Journal Article · · ACS Infectious Diseases
 [1];  [1];  [1];  [2];  [1];  [1];  [1]; ORCiD logo [3];  [2]; ORCiD logo [1]; ORCiD logo [4]
  1. Univ. of Kentucky, Lexington, KY (United States)
  2. Centers for Disease Control and Prevention, Atlanta, GA (United States). National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Tuberculosis Elimination
  3. Univ. of Michigan, Ann Arbor, MI (United States)
  4. Univ. of Kentucky, Lexington, KY (United States); Univ. of Michigan, Ann Arbor, MI (United States)

A common cause of resistance to kanamycin (KAN) in tuberculosis is overexpression of the enhanced intracellular survival (Eis) protein. Eis is an acetyltransferase that multiacetylates KAN and other aminoglycosides, rendering them unable to bind the bacterial ribosome. By high-throughput screening, a series of substituted 1,2,4-triazino[5,6b]indole-3-thioether molecules were identified as effective Eis inhibitors. In this work, we purchased 17 and synthesized 22 new compounds, evaluated their potency, and characterized their steady-state kinetics. Four inhibitors were found not only to inhibit Eis in vitro, but also to act as adjuvants of KAN and partially restore KAN sensitivity in a Mycobacterium tuberculosis KAN-resistant strain in which Eis is upregulated. A crystal structure of Eis in complex with a potent inhibitor and CoA shows that the inhibitors bind in the aminoglycoside binding site snugly inserted into a hydrophobic cavity. These inhibitors will undergo preclinical development as novel KAN adjuvant therapies to treat KAN-resistant tuberculosis.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
National Institutes of Health (NIH); Firland Foundation; Center for Chemical Genomics (CCG); University of Kentucky
Grant/Contract Number:
AI090048
OSTI ID:
1464833
Journal Information:
ACS Infectious Diseases, Vol. 4, Issue 6; ISSN 2373-8227
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 17 works
Citation information provided by
Web of Science

References (22)

Tuberculosis 2015: burden, challenges and strategy for control and elimination journal June 2016
Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis journal November 2016
Drug-Resistant Tuberculosis journal June 2016
New agents for the treatment of drug-resistant Mycobacterium tuberculosis journal July 2016
Resistance in tuberculosis: what do we know and where can we go? journal January 2013
Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis journal November 2009
Aminoglycoside Cross-Resistance in Mycobacterium tuberculosis Due to Mutations in the 5′ Untranslated Region of whiB7 journal February 2013
Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosis journal May 2011
Unusual regioversatility of acetyltransferase Eis, a cause of drug resistance in XDR-TB journal May 2011
Chemical and Structural Insights into the Regioversatility of the Aminoglycoside Acetyltransferase Eis journal September 2013
Effects of Altering Aminoglycoside Structures on Bacterial Resistance Enzyme Activities journal May 2011
Cosubstrate Tolerance of the Aminoglycoside Resistance Enzyme Eis from Mycobacterium tuberculosis journal September 2012
A Random Sequential Mechanism of Aminoglycoside Acetylation by Mycobacterium tuberculosis Eis Protein journal April 2014
Identification and Characterization of Inhibitors of the Aminoglycoside Resistance Acetyltransferase Eis from Mycobacterium tuberculosis journal September 2011
Potent Inhibitors of Acetyltransferase Eis Overcome Kanamycin Resistance in Mycobacterium tuberculosis journal April 2016
Sulfonamide-Based Inhibitors of Aminoglycoside Acetyltransferase Eis Abolish Resistance to Kanamycin in Mycobacterium tuberculosis journal November 2016
Discovery and Optimization of Two Eis Inhibitor Families as Kanamycin Adjuvants against Drug-Resistant M. tuberculosis journal September 2016
Combating Enhanced Intracellular Survival (Eis)-Mediated Kanamycin Resistance of Mycobacterium tuberculosis by Novel Pyrrolo[1,5- a ]pyrazine-Based Eis Inhibitors journal October 2016
Overexpression and Mechanistic Analysis of Chromosomally Encoded Aminoglycoside 2′- N -Acetyltransferase (AAC(2′)-Ic) from Mycobacterium tuberculosis journal October 2001
The Kinetic Mechanism of AAC(3)-IV Aminoglycoside Acetyltransferase from Escherichia coli journal December 2005
Exploring the Substrate Promiscuity of Drug-Modifying Enzymes for the Chemoenzymatic Generation of N-Acylated Aminoglycosides journal November 2009
Prodigious substrate specificity of AAC(6′)-APH(2′'), an aminoglycoside antibiotic resistance determinant in enterococci and staphylococci journal February 1999

Cited By (3)

Peptidoglycan pathways: there are still more! journal January 2019
Mycobacterial Aminoglycoside Acetyltransferases: A Little of Drug Resistance, and a Lot of Other Roles journal January 2019
The Role of Antibiotic-Target-Modifying and Antibiotic-Modifying Enzymes in Mycobacterium abscessus Drug Resistance journal September 2018

Figures / Tables (8)